<DOC>
	<DOCNO>NCT01959191</DOCNO>
	<brief_summary>Objective : To evaluate early late prognosis patient accord platelet reactivity clopidogrel administration determine whether measurement platelet inhibition predict 1-year clinical outcome off-pump coronary bypass ( OPCAB ) Study design - Prospective , observational , single-center study - Subjects OPCAB surgery meet inclusion exclusion criterion enrol . - Platelet reactivity 7-days clopidogrel treatment day surgery measure VerifyNow system . - Dual antiplatelet therapy include aspirin clopidogrel administer 1 year surgery subject followed-up 1 year primary endpoint . - Cutoff value P2Y12 reactivity unit ( PRUs ) primary endpoint assess cohort divide PRU cutoff value ( low/high platelet reactivity group ) . - The primary secondary endpoint compare two group</brief_summary>
	<brief_title>Clinical Significance Platelet Reactivity Clopidogrel During Off-pump Coronary Artery Bypass</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Patients indication surgical myocardial revascularization Patients undergo offpump coronary artery bypass Age 19~80 year Patients sign informed consent Patients combine surgery coronary bypass graft Onpump conversion Patients moderate renal dysfunction ( creatinine &gt; 2.0mg/dl ) need dialysis Patients chronic treatment proton pump inhibitor Patients preoperative bleeding Thrombocytopenia ( Platelet count 70,000/ml ) Redo surgery Early death measurement platelet reactivity</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Platelet activity , CABG , off-pump surgery</keyword>
</DOC>